InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: None

Thursday, 11/03/2016 8:57:00 PM

Thursday, November 03, 2016 8:57:00 PM

Post# of 977
Notes from abstract:

The DLBCL pt who experienced progression-free interval of 161 days is getting .05 mg/kg which is only 25% of the selected dose.

Manageable, dose-dependent thrombocytopenia was likely due to increased phagocytic clearance of platelets.

Macrophage-associated cytokines, including MIP-1a and MIP-1ß, increased during the 4 hrs after infusion